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Purpose: Physical inactivity is associated with increased risk of cardiovascular disease and 
myocardial dysfunction. High intensity interval training (HIIT) has been shown to improve 
cardiovascular health; however, adaptations of cardiac structure and function are uncertain. 
Therefore, the aim of the present study was to analyse cardiac structural and functional 
adaptations to a HIIT protocol.   
Methods: Forty-one physically inactive individuals (males n=20 and females n=21) were 
randomised into either a 4-week HIIT intervention or control group. The HIIT consisted of 3 
x 30-second maximal cycle ergometer sprints against a resistance of 7.5% body weight, 
separated by 2-minute active recovery periods. In total, 12-sessions were performed. All 
cardiac structural and functional parameters were measured by quantitative 2D transthoracic 
echocardiography, performed using a commercially available, portable ultrasound system 
(Vivid‐q, GE Healthcare, Milwaukee, Wisconsin) with a 1.5–3.6 MHz phased array 
transducer (M4S‐RS Matrix cardiac ultrasound probe).  
Results: The HIIT intervention produced significant improvements in resting heart rate 
(65.59 ± 10.15 to 63.05 ± 13.42 b·min-1, P=0.013), stroke volume (55.48 ± 16.27 to 64.24 ± 
20.62ml, P=0.015), left ventricular end diastolic volume (115.59 ± 28.34 to 131.94 ± 
33.40ml, P=0.025), E/a ratio (1.98 ± 0.48 to 1.95 ± 0.55; P=0.027), average E/e’ ratio (5.41 ± 
1.17 to 5.22 ± 0.89; P=0.002) and isovolumetric relaxation time (81.23 ± 12.85 to 77.83 ± 
9.81 m·s-1; P=0.022) compared to the control group. 
Conclusion: HIIT produced significant improvements in resting haemodynamics and 
diastolic function. This time efficient exercise intervention produces important improvements 
in myocardial function in a physically inactive population, which may be of clinical 
importance in higher risk populations.   
5 
 
1.0: Introduction and Literature Review 
1.1: The Cardiovascular System: A Brief Overview  
 
The cardiovascular system is an organ system that is composed of the heart, blood vessels 
and blood (Silverthorn, 2009). The primary function of the cardiovascular system is the 
circulation and transport of materials to and from all parts of the body (Tortora, & 
Derrickson, 2011). The substances transported by the cardiovascular system can be separated 
into materials that enter the body from an external environment such as oxygen, nutrients and 
water, materials moved from cell to cell such as wastes, immune cells, antibodies, hormones 
and stored nutrients, and waste material that cells eliminate from the body such as metabolic 
waste, heat, carbon dioxide and urea (Willmore, Costill & Kenny, 2008).  
The efficiency of the cardiovascular system to function at optimal levels is dependent upon 
numerous factors (Willmore, Costill & Kenny, 2008). Cardiac output is the volume of blood 
pumped by one ventricle in a minute, it has been noted that the average total blood volume is 
approximately 5 litres from the ventricle per minute (Silverthorn, 2009). However, it has been 
documented that cardiac output is not a fixed value, it continually changes in response to 
body demands (McArdle, Katch, & Katch, 2010). It has been found that during exercise 
cardiac output may increase to 30-35 Lmin-1 (McArdle, Katch, & Katch, 2010). Homeostatic 
changes in cardiac output is a result of varying heart rate, stroke volume or both (Berne & 
Levy. 1992). Stroke volume, the volume of blood ejected from the left ventricle per 
contraction, is directly related to the force generated by the cardiac muscle during systole 
(Berne & Levy. 1992). The force of ventricular contraction is affected by two parameters, the 
length of muscle fibres at the beginning of contraction and the contractility of the heart 
(Silverthorn, 2009). The energy of contraction can be increased by preloading of the 
myocardium during diastole through raising the end-diastolic pressure, which enhances the 
contractile energy; this relationship is known as the Frank-Starling law of the heart (McArdle, 
Katch, & Katch, 2010). However, it has been documented that if an individual has a high risk 
of cardiovascular disease, the function of the cardiovascular system can become significantly 
impaired (Kobirumaki-Shimozawa et al. 2014).                  
1.2: Cardiac Cycle  
 
The cardiac cycle refers to the repeating sequence of myocardial contraction and relaxation 
(Stouffer, Klein & McLaughlin, 2017). The contraction phase is referred to as systole and the 
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relaxation period is known as diastole (Nishimura & Tajik, 1997). As the human heart has 
four chambers there is atrial systole, atrial diastole, ventricular systole and ventricular 
diastole (Levick, 2010). Atrial contraction occurs during ventricular diastole and atrial 
relaxation occurs during ventricular systole (Nishimura & Tajik, 1997). The heart therefore 
has a two-step pumping action (Powers & Howley, 2001). The left atrium and right atrium 
simultaneously contract, emptying atrial blood into the ventricles (Cox et al. 1995). 
Approximately 0.1 seconds after atrial contraction, the ventricles contract and deliver blood 
into both the systemic and pulmonary circuits (Levick, 2010). The cardiac cycle is divided 
into four phases based on the positions of the inlet and outlet valves (Levick, 2010). These 
phases are ventricular filling, isovolumetric contraction, ejection and isovolumetric relaxation 
(Levick, 2010).  
Ventricular filling has two major determinants, ventricular relaxation and effective chamber 
compliance (Nishimura & Tajik, 1997). At rest, ventricular diastole occupies approximately 
two-thirds of the cardiac cycle, which provides adequate time for the ventricles to fill 
(Powers & Howley, 2001). During the initial rapid filling phase, ventricular pressure falls, 
which is due to the relaxing ventricle recoiling elasticity from its deformed end-systolic 
shape. Once the pressure in the left ventricle drops to below the pressure in the left atrium, 
the mitral valve opens, causing accumulated blood from the atrium to be sucked into the 
ventricle (Nishimura & Tajik, 1997). As ventricular filling begins, the atria is also in diastole, 
allowing passive blood flow from the great veins through the atria and the open 
atrioventricular valves into the ventricles (Powers & Howley, 2001). This initial phase is very 
fast lasting approximately 0.15 seconds (Pocock & Richards, 2006). Further filling is caused 
by the venous pressure, which distends the ventricle and causes ventricular pressure to rise 
gradually (Pocock & Richards, 2006). The finally third stage of the filling phase is atrial 
contraction (Pocock & Richards, 2006).  At the end of the filling phase the volume of blood 
in the ventricle is known as end-diastolic volume (EDV) (Pocock & Richards, 2006). 
The ventricular filling velocity has two main components; firstly the early (E) diastolic phase 
which causes ventricular suction, and second, a late phase created by atrial contraction (A) 
(Keren et al. 1988). The E/A ratio is of importance as it can be used as a diagnostic measure, 
since the ratio is reduced in diastolic dysfunction (Paulus et al. 2007).   
Ventricular systole follows atrial systole; this is divided into a brief isovolumetric phase and a 
longer ejection phase which lasts approximately 0.35 seconds (Levick, 2010). As the pressure 
in the ventricles rises just above atrial pressure the atrioventricular valves are closed by the 
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reversed pressure gradient (Pocock & Richards, 2006). During atrioventricular valve closure 
the backflow of blood is minimal due to vortices approximate the valve cusps during the late 
filling phase (Pocock & Richards, 2006). As the ventricles temporarily become a closed 
chamber, the tension of its contracting walls causes the pressure of the trapped blood to rise 
rapidly (Levick, 2010).  
As the ventricular pressure exceeds arterial pressure, the outflow valves are pushed open and 
ejection begins (Levick, 2010). Initially there is a rapid ejection phase which results in three 
quarters of the stroke volume being ejected, this makes up half of the ejection phase (Levick, 
2010). During this rapid ejection phase the blood is ejected faster than it can drain away 
through the peripheral vessels, therefore, most of the stroke volume is accommodated 
temporarily in the distended elastic arteries (Nishimura & Tajik, 1997). This causes the 
arterial pressure to increase to its maximum systolic level (Pocock & Richards, 2006). During 
ejection, the cusps of the open aortic valve lie close to the entrances to the coronary arteries, 
but do not block them because vortices behind the cusps cause them to float between 
midstream and the aorta wall (Pocock & Richards, 2006). During late systole, ejection rate 
slows down, when the rate at which aortic blood is draining away into the peripheral 
circulation now exceeds ventricular ejection, pressure begins to fall (Pocock & Richards, 
2006). Although ventricular pressure drops to 2-3mmHg below arterial pressure, the outward 
momentum of the blood prevents immediate closure of the aortic valve (Stouffer, Klein & 
McLaughlin, 2017). However, the reversed pressure gradient causes the outflow to gradually 
decelerate, until a brief backflow closes the outflow valve (Levick, 2010). This backflow is 
typically less than 5% of the stroke volume, although this can increase greatly if the aortic 
valve is incompetent (Levick, 2010). Valve closure creates a notch in the arterial pressure 
trace called the incisura (Pocock & Richards, 2006). For the rest of the cycle, the arterial 
pressure decreases gradually as blood drains away into the periphery (Stouffer, Klein & 
McLaughlin, 2017). In a resting human, only two thirds of the end diastolic blood volume is 
ejected (Levick, 2010). Stroke volume is 70-80ml and the end diastolic volume is 
approximately 50ml (Levick, 2010). Ejection fraction is the stroke volume divided by end 
diastolic volume, with a normal value of >55% (Pocock & Richards, 2006). The end systolic 
volume serves as reserve that can be drawn on to raise the stroke volume and ejection fraction 
during exercise (Levick, 2010).     
As the aortic and pulmonary valves close, the ventricles briefly become closed chambers, the 
elastic recoil of the deformed, relaxing myocardium causes the ventricular blood pressure to 
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fall rapidly (Levick, 2010). As ventricular blood pressure falls below atrial pressure, the 
pressure difference pushes open the atrioventricular valves, terminating the isovolumetric 
relaxation phase (Pocock & Richards, 2006). Blood floods in from the atria which have filled 
during ventricular systole, starting the next cardiac cycle (Levick, 2010).  
1.3: Cardiovascular Disease 
 
Cardiovascular disease (CVD) is the largest contributor to global mortality (Mills et al, 
2015), accounting for nearly half of the 36 million annual non-communicable disease deaths, 
surpassing communicable diseases as the world’s major disease burden (Smith et al. 2012). 
CVD is approximately accountable for 17.3 million deaths every year (Townsend et al, 2015) 
and is responsible for 30.8% of all deaths annually (Uppoor et al, 2015). By 2030, CVD is 
projected to account for 25 million deaths worldwide (Okwuosa et al, 2016). In 2014, CVD 
was the second most common cause of death in the United Kingdom (UK), accounting for 
approximately 155,000 deaths, 27% of all deaths within the UK (Townsend et al, 2015). 
CVD was responsible for approximately 41,000 premature deaths in the UK, in total 25% of 
premature deaths in men and 17% of premature deaths in women (Townsend et al, 2014). 
More than £6.8 billion was spent on treating CVD within the NHS in England in 2012/ 2013 
(Townsend et al, 2014). The biggest single cause of death in the UK from CVD is a chronic 
disease known as coronary artery disease (CAD), which accounts for more than 73,500 
deaths each year (Bhatnager et al, 2015). CAD was responsible for 15% of male deaths and 
10% of female deaths in the UK in 2014 (Townsend et al. 2015). CAD is a condition where 
the arteries become hardened, narrowed and less flexible by the build-up of lipids, 
inflammatory cells, and connective tissue within their intimal layer, the gradual build-up of 
which stops the delivery of oxygenated blood to the heart (McArdle, Katch & Katch, 2010).  
1.4: Hypertension 
 
Chronic high blood pressure, or hypertension, is the most predominant pre-curser of CVD 
and deaths globally (He & Whelton, 1997). Hypertension has been found to affect 
approximately 1 billion individuals worldwide (Krum et al. 2014), estimated to account for 
7.6 million deaths each year attributable to hypertension (Chow et al. 2013). It is expected 
that by 2025 the number of individuals affected with hypertension is expected to rise to 1.6 
billion (Krum et al. 2014). The National Health Service (NHS) was shown to spend more that 
£6.8 billion in 2012/2013 on the treatment of CVD (Townsend et al. 2014). Hypertension has 
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been shown to effect one in four adults within the UK and as a result one in five heart attacks 
is attributed to hypertensive heart disease (Thompson, 2015). 
Hypertension has been linked with having an increased risk of developing cardiovascular 
diseases (Chobanian et al. 2003), such as CAD (Stamler, Stamler & Neaton, 1993), stroke 
(Lee et al. 2004), heart failure (Levy et al. 1996), myocardial infarction (Uppoor et al. 2015), 
left ventricular hypertrophy (Messerli & Aepfelbacher, 1995), chronic kidney disease (Sarnak 
et al. 2003) and other chronic diseases such as retinopathy (Wong & Mitchell, 2004), cerebral 
haemorrhage (Qureshi et al. 2001) and hypertensive encephalopathy (Schwartz et al. 1992). 
For people suffering with hypertension the risk for cardiac complication has been shown to 
be greater (Bogousslavsky et al. 1996), for example patients who have ischaemic heart 
disease are 40% more likely to have a fatal myocardial infarction when they have previously 
suffered with hypertension (Dunn, 1983). The risk of CVD has been shown to double with 
every 20 and 10 mmHg increase in systolic and diastolic blood pressure respectively after the 
age of 40 (Kannel, 2009).  
Hypertension induces endothelial dysfunction (Chobanian et al, 2003), which is considered 
the initiating step of atherosclerosis pathogenesis (Huynh et al, 2011). Atherosclerosis is a 
multifocal, immunoinflammatory disease of medium-sized and large arteries stimulated by 
lipids (Falk, 2006). Due to inflammation, the smooth muscle cells and endothelial cells 
proliferate in the intima, creating extracellular matrix molecules which form into 
atherosclerotic plaques (Ross, 1999). This may result in flow limiting stenosis and cause 
clinical symptoms such as stable angina (Nabel & Braunwald, 2012). This process has been 
shown to result in poorer quality of life (Battersby et al, 1995), chronic diseases and possibly 
a fatal myocardial infarction (Gazmararian et al, 2003; Rakugi et al, 1996).  
 
Blood pressure ranging from 120-139mmHg systolic or from 80-89mmHg diastolic in adults 
is defined as pre-hypertension (Chobanian et al. 2003). Pre-hypertension has increasingly 
been recognized as a contributing factor to CVD risk (Santos et al. 2016). The relative risk of 
CVD in persons with pre-hypertension has been found to be 2.3-fold higher than for those 
with optimal blood pressure (Kshirsagar et al. 2006), this risk has been found to be even 
greater in individuals with other risk factors such as diabetes, low-density lipoprotein 100-
129 mgdl-1, or body mass index greater than 30 kgm2 (Kshirsagar et al. 2006). Recent meta-
analyses have found that pre-hypertension increases the risk of CAD and stroke independent 
of other cardiovascular risk factors (Huang et al. 2015; Huang et al. 2013; Guo et al. 2013).  
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A recent prospective epidemiologic study by Santos et al. (2016), designed to investigate 
atherosclerotic disease in 4871 participants found that pre-hypertension may be associated 
with preclinical target organ damage. The study categorised the participants into 3 groups: 
optimal blood pressure (blood pressure <120mmHg systolic and <80mmHg diastolic) (n = 
402), pre-hypertension (n = 537) and hypertension (n = 3932) and analysed the alterations in 
cardiac structure and function between the groups. The study found that individuals with pre-
hypertension had higher left ventricular mass index and wall thickness and higher prevalence 
of abnormal left ventricular geometry compared with those who have optimal blood pressure, 
however both are lower than individuals with hypertension. Additionally, the participants 
with pre-hypertension were shown to have impaired diastolic parameters such as E/A ratio, 
E’ and E/E’, and had a higher prevalence of mild and moderate-severe diastolic dysfunction 
compared with those with optimal blood pressure, however no differences in systolic 
parameters were observed. The results from this study coincide with the generally accepted 
notion that pre-hypertension is associated with an augmented risk of progression to 
hypertension (Leitschuh et al. 1991), and the linear and continuous relationship between 
blood pressure levels and cardiovascular events (Lewington et al. 2002). They also suggest 
that even mildly elevated blood pressure within the normal range is associated with cardiac 
end-organ damage.  
 
1.5: Left Ventricular Hypertrophy 
 
Systemic hypertension has been shown to cause an increase to myocardial workload, which 
has been found to lead to cardiac enlargement because of increased rate of myocardial and 
hyperplasia cells or continuation of hyperplasia beyond the normal period of hyperplastic 
growth (Oparill, Bishop & Clubb, 1984). As an effect to cellular enlargement, structural 
remodelling of the myocardial cells, which consists of modifications in the relative 
proportions of cellular organelles and in the ultrastructure of individual organelles, occurs 
during the development of hypertrophy in the heart (Oparill, Bishop & Clubb, 1984). The 
materialisation of left ventricular hypertrophy (LVH) is a strong independent risk factor for 
cardiovascular disease and all-cause mortality (Laine et al, 1999). LVH is the most 
significant predictor of adverse cardiovascular outcomes in the hypertensive population, and 
is an independent risk factor for CAD, sudden death, heart failure and stroke (Gradman & 
Alfayoumi, 2006). Patients who suffer with hypertension and LVH, because of myocardial 
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workload, are at a 10-fold greater risk of developing cardiovascular disease than those with 
hypertension and normal LV mass (Vogt et al, 1993).   
 
1.6: Myocardial Dysfunction 
 
CVD such as hypertension, CAD and cardiomyopathies often lead to systolic and diastolic 
dysfunction (Redfield et al. 2003). Diastolic dysfunction is characterised by an increased 
resistance to filling with increased filling pressures (Federmann & Hess, 1994). There is 
growing recognition that congestive heart failure caused by a predominant abnormality in 
diastolic function is both common and causes significant morbidity and mortality (Zile & 
Brutsaert, 2002). Research has shown that diastolic dysfunction is an independent predictor 
of mortality in patients with normal left ventricular ejection fraction (AlJaoundi et al. 2012). 
Approximately half of all patients suffering with congestive heart failure have diastolic 
dysfunction without reduced ejection fraction (Redfield et al. 2003). Diastolic dysfunction is 
graded as either mild (impaired relaxation), moderate (pseudonormal), or severe (restrictive 
filling) (AlJaoundi et al. 2012). The more advanced the stage is, the higher the filling 
pressures are and the worse the outcomes (AlJaoundi et al. 2012).  
Diastolic dysfunction develops early in most cardiac diseases and leads to the elevation of LV 
filling pressures (Nagueh et al. 2009). Diastolic dysfunction refers to abnormalities of active 
myocardial relaxation and passive ventricular filling (Zile & Brutsaert, 2002). It can be 
attributed to one of four underlying conditions (Kapila & Mahajan, 2009). The most common 
cause is slow myocardial relaxation, due to myocardial ischaemia, causing a reduced rate of 
left ventricle pressure decline. In patients with LVH any degree of ischaemia or functional 
impairment of relaxation is greater, making them more susceptible to diastolic dysfunction 
(Ix et al. 2006). A second condition is impaired peak left ventricle filling rate due to the 
failure to generate an adequate transmitral pressure gradient, this occurs typically to either 
elevated left ventricular pressures or the inability to generate left ventricular suction (Kapila 
& Mahajan, 2009). Another condition is a result of alterations in cytoskeleton properties 
leading to passive viscoelastic stiffness of the left ventricle. Myocardial fibrosis is initiated by 
neurohumoral responses that leads to decreased left ventricular compliance (Kapila & 
Mahajan, 2009). The final underlying condition causing diastolic dysfunction is mechanical 
obstruction to left ventricular expansion raising left ventricular pressure to transmitral 
pressure more rapidly, terminating left ventricle filling earlier (Kapila & Mahajan, 2009). The 
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net effect of all these pathological processes is a higher LV end-diastolic pressure for any 
given LV end-diastolic volume (Kapila & Mahajan, 2009).  
Di Bello et al. (2010) study, examining left ventricular mechanics in persons with pre-
hypertension, found that there is evidence of abnormalities in early and global diastolic 
function. Compared to normotensive individuals the peak E wave was found to be 
progressively lower in pre-hypertension and hypertension patients, however, late diastolic left 
ventricular functional phase was comparable across the three groups. Analysis of the pulsed 
wave tissue Doppler imaging at mitral annulus level, showed that there is subtle modification 
of diastolic longitudinal function (E’) and the E/E’ ratio (a non-invasive measure of left 
ventricular filling pressure) showed a progressive and significant increase in pre-hypertension 
and hypertension patients in comparison with normotensive individuals, confirming that only 
the early phase of longitudinal diastolic function is impaired. This indicates that mild left 
ventricular diastolic dysfunction occurs during pre-hypertension. However, it is important to 
note that the study used a relatively small population, therefore the results cannot be 
generalised to the pre-hypertensive population, further longitudinal investigations are needed 
to better clarify these preliminary findings.      
Left ventricular failure can be separated into systolic and diastolic dysfunction (Hess, 1993).  
Systolic dysfunction is determined by an impaired pump function with reduced ejection 
fraction and an enlarged end-diastolic chamber volume (Federmann & Hess, 1994). The most 
common cause of heart failure is left ventricular systolic dysfunction (McDonagh et al. 
1998). Most cases of systolic dysfunction are a result of end stage CAD with either a 
previous myocardial infarction or with a chronically under-perfused myocardium (Fox et al. 
2008). Other common causes include hypertensive heart disease, idiopathic dilated 
cardiomyopathy, valvular heart disease and congenital heart disease (Redfield et al. 2003).  
Systolic dysfunction can be defined as having a left ventricular ejection fraction less than 
40% (Vasan et al. 1999). In chronic heart failure this is most likely due to alterations in the 
transduction mechanisms regulating cardiac excitation-contraction coupling (Federmann & 
Hess, 1994). This causes a loss of cardiac inotropy causing a downward shift in the Frank-
Starling curve, resulting in a decreased stroke volume and a compensatory rise in preload 
because of incomplete ventricular emptying, causing an increase in ventricular end-diastolic 
volume and pressure (Hess, 1993). The rise in preload is compensatory because it activates 
the Frank-Starling mechanism to help maintain stroke volume despite the loss of inotropy 
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(Hess, 1993). The negative adaptations as a consequence of these compensatory mechanisms 
is higher wall stress and higher oxygen requirements, these effects are reduced by subsequent 
myocardial hypertrophy, activation of the baroreceptor reflex and release of atrial natriuretic 
peptide (Federmann & Hess, 1994). The baroreceptor reflex inhibits sympathetic activation 
and atrial natriuretic peptide exerts diuretic and vasodilating effects (Federmann & Hess, 
1994). 
Patients with heart failure as a result of left ventricular systolic dysfunction regularly develop 
mitral regurgitation due to unfavourable alterations in ventricular geometry (Wu et al. 2005). 
This leads to deformation of the normal mitral valve apparatus and dilation of the ventricle 
chamber, which in turn leads to incomplete closure of the mitral valve cusps (Kono et al. 
1992). The presence of mitral regulation in the setting of systolic dysfunction is associated 
with increased mortality (Robbins et al. 2003).      
1.6: Physical Activity  
 
In recent decades, major advances have been made in the understating of the pathogenesis of 
CAD and in the development of diagnostic methods and treatment modalities (Pyörälä et al. 
1994). Measures aimed at CAD prevention focus on modification of lifestyles and reducing 
risk factors that are known to be casually linked with the development of atherosclerosis, the 
underlying disorder for CAD (Thompson et al. 2003). Four areas of risk factor modification 
have received particular attention, specifically cessation of smoking, increase exercise 
participation, treatment of elevated blood pressure and hypercholesterolaemia, because these 
risk factors have been considered to be the four major risk factors of CAD (Chobanian et al. 
2003). There is evidence that indicates that risk factor modification is also effective in 
reducing the risk of recurrent CAD events in patients with clinically manifest CAD and, more 
recently, evidence that this can lead to a retardation or even a halt to the progression of 
coronary atherosclerosis. It has also been shown that risk factor modification reduces CAD 
risk in asymptomatic high risk subjects (Pyörälä et al. 1994).  
Elevated blood pressure was the first risk factor to become a subject of specific 
recommendations (Pyörälä et al. 1994). It has been well reported that hypertension is a 
modifiable risk factor that when treated can reduce the risk of mortality (Sacco et al, 1997). 
Changes in life style such as participating in regular exercise (Ebrahim & Smith, 1998), 
reducing salt intake (Meneton et al. 2005), and reducing alcohol intake (Puddey, Beilin & 
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Vandongen, 1987) have been shown to positively affect the treatment of hypertension 
(Chobanian et al. 2003). Prospective epidemiological studies give strong support to the view 
that a sedentary lifestyle is associated with an increased risk of hypertension and CAD 
(Pyörälä et al. 1994).  
Physical inactivity can be used as a term to identify individuals who do not meet the 
recommended level of physical activity (Townsend et al. 2015). It has been estimated that 
physical inactivity contributes to approximately 10% of all deaths worldwide from non-
transmissible diseases (Lee et al. 2012). Although progress has been made in the prevention, 
detection, control and treatment of hypertension, it has been established that the adoption and 
adherence to long term exercise and fitness programs are much lower than expected. It has 
been reported that 31% of the global population are not currently meeting the 
recommendations for exercise (Hallal et al. 2012). Approximately only 50% of all individuals 
who begin participating in an exercise program will continue the habit for a period longer 
than 6 months (Bartlett et al. 2011). The issue of non-adherence is vital as the beneficial 
health effects of exercise are only maintained if exercise is maintained for extended periods 
of time (Fletcher et al. 1996). If the issue of non-adherence to exercise was addressed by 
developing strategies to improve exercise initiation, then the cardiovascular risks associated 
with hypertension could be reduced (King et al, 1992). Additionally, it has been noted that 
approximately 240,000 newly diagnosed chronic diseases each year have been attributed to 
physical inactivity (Martin et al. 2009). The national cost of medical bills attributed to 
physical inactivity within the UK has been estimated to amount to £1.06 billion (Allender et 
al. 2007).  
Physical activity can be defined as any bodily movement produced by skeletal muscles that 
results in energy expenditure beyond resting expenditure (Thompson et al. 2003). The 
recommended amount of physical activity performed on a weekly basis is currently 30 
minutes of tradition aerobic exercise 5-7 days a week (Townsend et al. 2015) or 20 minutes 
vigorous intensity exercise 3 days per week (Haskell et al. 2007).  Regular physical activity 
has been shown to produce cardiovascular adaptations that increase exercise capacity, 
endurance and skeletal muscle strength (Thompson et al. 2003). Maximal aerobic capacity 
increases due to the cardiovascular systems increased capacity to deliver oxygen to the 
muscles, via an increased cardiac output, and the capability of the muscles to extract and 
utilise oxygen, which is reflected by the greater arteriovenous oxygen difference (Thompson, 
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2005). This process is demonstrated by the Fick equation, which is calculated as maximal 
aerobic capacity = cardiac output x arteriovenous oxygen difference (Albouaini et al. 2007). 
It is also evident that regular physical activity can be a low cost non-pharmacological 
intervention in the prevention and management of chronic diseases (Thompson et al. 2003). 
Lee & Skerrett (2001) found that there is a transparent inverse relationship between the 
capacity of physical activity and all-cause mortality rates in men and women, of all ages, and 
that adherence to the recommended guidelines for physical activity resulted in approximately 
20-30% reduction in all-cause mortality. It has been hypothesised that if worldwide 
participation in physical activity increased by approximately 10%, then almost 500,000 
deaths each year as a consequence of physical inactivity could be averted (Lee et al. 2012). 
Research shows that habitual physical activity prevents the development of CAD and reduces 
symptoms in patients with established cardiovascular disease (Durstine et al. 2000). Regular 
physical activity has been shown to cause adaptations in vascular function as a result of 
arterial sheer stress being used as a stimulus to trigger anti-atherosclerotic adaptations and 
vascular remodelling within the vascular system, helping to prevent the onset of age-related 
decline in indices of vascular function (Green, 2009). These adaptations are supported by 
Haskell et al. (1993), who found that physically active males have an increased coronary 
artery size and dilation capacity when compared to sedentary individuals. It has been 
documented that physically active individuals have endothelial adaptations in conduit arteries 
as a result of increased shear stress rate as a result of exercise (Green et al. 2011). The 
possible mechanisms prompting vasodilatory adaptations include increases in endothelial 
nitric oxide synthase and prostaglandin release as well as declines in free-radical-mediated 
nitric oxide degradation and sympathetic vasoconstrictor tone (Heydari, Boutcher & 
Boutcher, 2013). This increases the number of circulating endothelial progenitor cells, which 
results in greater endothelial regeneration and improved endothelial function (Hambrecht et 
al. 1998), reducing the risk of hypertension, the greatest precursor to cardiovascular disease 
(He & Whelton, 1997). The reduced risk of hypertension is supported by Fagard (2006), who 
found that physically active individuals have lower levels of plasma renin activity and less 
plasma noradrenaline compared to sedentary individuals. Following regular bouts of physical 
activity, heart rate variability and stroke volume have been shown to increase (Fletcher et al. 
2013). This is due to increased arterial baroreflex sensitivity because of inhibition of the 
sympathetic nervous system and activation of the parasympathetic nervous system 
(Lanfranchi & Somers, 2002).  
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Further research by Barlow et al. (2012) support the notion that it is beneficial to have a more 
physically active lifestyle compared to sedentary individuals. Over a 27 ± 2 year period, it was 
shown that it was significantly (P=0.001) more beneficial to be physically active, as these 
individuals had greater survival rates and were less likely to suffer from cardiovascular diseases 
compared to physically inactive individuals. Delaying and preventing the onset of hypertension 
may therefore have a large impact on public health, especially in individuals who are at a high 
risk for cardiovascular events (Mosca et al. 2004), such as established CAD patients (De 
Backer et al. 2003), asymptomatic individuals (Greenland, Smith & Grundy, 2001) and obese 
individuals (Mosca et al. 2004). It has also been documented that regular physical activity 
reduces the risk of other chronic diseases, including type 2 diabetes (Knowler et al. 2002), 
osteoporosis (Vuori, 2001), obesity (Wing & Hill, 2001), depression (Pollock, 2001) and 
cancer of the breast (Breslow et al. 2001) and colon (Slattery & Potter, 2002). 
1.7: Traditional Aerobic Training 
 
In accordance with current guidelines, adults are advised to participate in at least 150 minutes 
of moderate intensity exercise each week (Townsend et al. 2015). It has been documented 
that partaking in this amount of exercise, working at an intensity of 40-59% HRmax, is 
beneficial to cardiovascular health by reducing cardiovascular risk factors (Thompson et al. 
2003). This is demonstrated by the Cornelisson & Fargard (2005) meta-analysis, which 
included 72 trials of traditional aerobic training programmes, 105 study groups and 3936 
participants consisting of normotensive, pre-hypertensive and hypertensive participants. The 
reported findings indicated that a variety of variables associated with being beneficial to 
cardiovascular health improved. It is reported that VO2peak significantly increased (P < 0.001), 
which is an indicator of improved cardiovascular health (Keteyian et al. 2008). Significant 
reductions in systolic blood pressure (P < 0.001) and diastolic blood pressure (P < 0.001) 
were also reported, as well as a significant reduction in resting heart rate (P < 0.001). The 
impact on cardiac structure and function was not reported.    
Empirical research surrounding traditional aerobic training has also shown that it may lead to 
improvements in cardiac structure and function (Andrea et al. 2002). A relationship between 
athletic participation and specific cardiac morphology has been well established. Increased 
left atrial size and left ventricular mass, wall thickness, and chamber size have been 
documented among trained athletes, and some recent reports have also noted similar 
characteristics in the right ventricle (Andrea et al. 2002; Baggish et al. 2007). An early study 
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by Fagard et al. (1983) assessing the effects of traditional aerobic training versus a physically 
inactive control group, showed that 12 male cyclists aged between 17-35 years old in 
competitive season compared with the 12 control subjects, matched for age, height and 
weight, have significantly greater left ventricular internal dimensions (P < 0.05) and 
increased wall thickness (P <0.05), with similar left ventricular function.  
A more recent study by Baggish et al. (2007) reported that 40 recreational athletes, had 
significant training-specific changes in cardiac structure and function following a 90-day 
aerobic training programme. Following the aerobic training programme, the participants 
experienced significant increases in left ventricular mass (P < 0.05) and end-diastolic volume 
(P < 0.001) and a non-significant trend toward increased wall thickness. It was also reported 
that stroke volume was increased following the training protocol, however, resting cardiac 
output (due to a marked reduction in resting heart rate) was significantly reduced. These 
findings correlate with the previous study in that by following an aerobic training programme 
the participants experienced left ventricular hypertrophy and biatrial enlargement. In contrast 
the participants Bassigh’s study experienced significant increases in LV diastolic tissue 
velocities, which were positively correlated with the magnitude of LV mass increase. In 
aggregate, this data demonstrates direct evidence that traditional aerobic training produces 
left ventricular hypertrophy with associated augmentation of left ventricular function. 
It has been suggested that due to the time commitment and the physical challenges of 
performing aerobic training, many population groups find it challenging to adhere to an 
aerobic training programme (Gillen & Gibala, 2013). Therefore, it could be postulated that 
current physical activity guidelines could be a factor influencing non-adherence to exercise 
programmes and further research is needed to explore the adoption of vigorous intensity 
exercise.  
1.8: High Intensity Interval Training 
 
More recently, research has focused on the intensity of exercise, with high intensity interval 
training (HIIT) fast becoming a popular alternative to more traditional aerobic training 
programmes (Gibala et al. 2012). HIIT is a time-efficient exercise strategy that has been 
documented to elicit beneficial adaptations in cardiorespiratory function as well as 
enhancements in metabolic health (Schoenfeld & Dawes, 2009). Compared to more 
traditional aerobic training programmes, HIIT has been shown to produce significantly 
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greater improvements in 24-hour ambulatory systolic blood pressure and diastolic blood 
pressure, VO2max, total peripheral resistance, and left ventricular systolic and diastolic 
function in patients with hypertension and pre-hypertension (Sharman, La Gerche & 
Coombes, 2015). It has also been reported that sessions of HIIT (4 four minute intervals at 
95% HRmax) is more efficient than aerobic exercise (45 minutes at 70% HRmax) as it allows 
for greater improvements in cardiac output and stroke volume which can reduce strain upon 
the cardiac muscle, reducing the risk of metabolic disorders (Helgerud et al. 2007).  
HIIT refers to brief intervals of vigorous activity combined with periods of low activity or 
rest, and produces a strong cardiac response compared with aerobic exercise (Gibala et al. 
2012). It has been recognised that HIIT using a 30-secind Wingate protocol is sufficiently 
long enough to allow for developing the maximal glycolytic power and short enough for 
maximal effort to be exerted until the end of the bout (MacInnis & Gibala, 2017). The 
recovery period performed at a reduced intensity is designed so that the cardiopulmonary 
system does not fully recover to near resting levels, whilst allowing the individual enough 
recovery to be able to repeat the next bout of high intensity exercise (MacInnis & Gibala, 
2017). Research indicates that HIIT performed 3 times per week is adequate to decrease 
markers of chronic disease in both healthy individuals and people with cardio metabolic 
disorders (Shiraev & Barclay, 2012). As lack of time remains one of the main cited barriers to 
regular exercise participation, HIIT is a time-efficient exercise strategy that could be used to 
encourage exercise participation by fitness professionals and health practitioners (Gillen & 
Gibala, 2013).    
The adaptions observed after HIIT is said to be due to the metabolic rate being raised for a 
brief period that is considerably higher than that of traditional aerobic training, this permits a 
longer duration of a training period spent at a higher percentage of V02max (MacInnis & Gibala, 
2017). Research suggests that the relative intensity of cycling is more important than the 
duration in relation to all-cause mortality in healthy subjects (MacInnis & Gibala, 2017). 
There is increasing evidence that supports HIIT as a well-tolerated and safe training method, 
even amongst populations with high risk of cardiometabolic disease, the protocol can be 
adapted to the specific needs of the individual, with the work periods and recovery periods 
simply being adjusted to create a variety of different HIIT protocols (Arena et al. 2013). A 
meta-analysis on patients with lifestyle induced chronic diseases from Weston, Wisloff & 
Coombes (2014) support the potential cardiovascular health benefits of performing HIIT over 
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aerobic training programmes. Ten studies were included in the meta-analysis, all of which 
followed a randomised control trial protocol, assessing a cardio-metabolic chronic disease 
population, where physical inactivity was the main contributor. It can be noted that the meta-
analysis showed greater increases in Vo2max in the HIIT programme by 19.4% compared 
against a 10.9% increase in the aerobic training programme. The increase in Vo2max because 
of exercise training could be explained due to a higher maximum cardiac output and greater 
extraction of oxygen from the systemic circulation demonstrated in the participants, reflecting 
both central and peripheral adaptations (Fletcher et al. 1990). Greater central adaptations 
demonstrated in the meta-analysis include improved left ventricular ejection fraction in the 
HIIT group with no change in the aerobic training group, highlighting the potential for further 
left ventricular remodelling with HIIT (Wisloff et al. 2007). It was also found that cardiac 
function was improved with HIIT, in terms of stroke volume, mitral annular excursion, 
ejection velocity and systolic mitral annular velocity, demonstrating improvements in systolic 
and diastolic function that were not found with the aerobic training group. Increased maximal 
rate of calcium ions (Ca2+) uptake and greater reductions in resting blood pressure were also 
reported in the HIIT group. 
The effects of HIIT and the subsequent clinical benefits in both healthy and high-risk 
populations have been well documented within empirical literature (Gilbala et al. 2012). 
Evidence based research has investigated the effects of acute and chronic HIIT protocols on 
cardiac structure and function in healthy populations and chronic disease patients. A study by 
Cote et al. (2013) demonstrated that an acute bout of HIIT can cause alterations in cardiac 
mechanics in healthy individuals. Thirty-nine normally active and endurance trained men and 
women completed an echocardiographic evaluation of left ventricular function before and 
after an acute bout of HIIT. It was reported that following the HIIT session fractional 
shortening, wall stress, septal and lateral wall tissue velocities, and isovolumetric relaxation 
time were reduced (P < 0.05). It was also found that males demonstrated greater reductions in 
cardiac contractility compared to females, which may reflect differential intrinsic myocardial 
relaxation properties, the mechanisms of which require further research. The findings 
demonstrate that a single session of HIIT can alter cardiac function, leading to significant 
improvements in diastolic function, an independent predictor of cardiovascular morbidity and 
mortality (AlJaoundi et al. 2012). 
In addition, a chronic study of 12 weeks with a total of twenty-eight physically inactive 
participants investigated the effects of HIIT on cardiac structure and function in patients with 
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type 2 diabetes (Cassidy et al. 2015). The participants were randomised into either a HIIT 
(n=14) or control group (n=14). It was reported that left ventricular mass was significantly 
improved (HIIT: 104±17 g to 116±20 g vs Con: 107±25 g to 105±25 g, p<0.05) and systolic 
function through stroke volume was significantly improved (HIIT: 76±16 ml to 87±19 ml vs 
Con: 79±14 ml to 75±15 ml, p<0.01) following the HIIT programme. It was also reported 
that in the HIIT group early diastolic filling rates significantly increased (HIIT: 241±84 ml/s 
to 299±89 ml/s vs Con: 250±44 ml/s to 251±47 ml/s, p<0.05) and peak torsion significantly 
decreased (HIIT: 8.1±1.8° to 6.9±1.6° vs Con: 7.1±2.2° to 7.6±1.9°, p<0.05). The increase in 
early diastolic filling demonstrates improve diastolic function, suggesting that the 
myocardium has become more compliant and quicker to relax following HIIT. This is 
clinically significant as diastolic dysfunction is an independent predictor of cardiovascular 
morbidity and mortality (AlJaoundi et al. 2012). 
A study by Molmen-Hansen et al. (2012) investigated the effects of moderate aerobic training 
and HIIT on cardiac function and blood pressure in patients with hypertension. The 
participants were randomised into three groups, either the HIIT group (n=31), aerobic 
training group (n=28) or the control group (n=29). The results show that HIIT was superior to 
aerobic training in terms of improved cardiac function, aerobic capacity and reducing mean 
heart rate. It was reported that only the HIIT group had an improvement in left ventricular 
ejection fraction, stroke volume, systolic flow velocity, end-diastolic volume (11%, p < 0.01), 
and early diastolic mitral annulus tissue velocity, E’ (14%, p < 0.001). It was also found that 
systolic mitral annulus tissue velocity, S’ increased by 15% (p < 0.001) after HIIT and 8% (p 
< 0.04) after aerobic training. The isovolumetic relaxation rate decreased significantly in the 
HIIT group only, by 16% (p < 0.01). However, it could be argued that despite positive 
results, the long duration on the HIIT sessions (38 mins) may be too long and participants 
may not adhere to sessions of this duration in the long term.  
The results from this study coincide with Weston, Wisloff & Coombes (2014) meta-analysis 
who found that there was a greater improvement in in heart rate, systolic and diastolic 
function in patients with hypertension following HIIT when compared to aerobic training. 
However, it can be noted that the results differ in terms of changes in myocardial structure, 
therefore it can be suggested that more research is needed to further understand the 
relationship between HIIT and hypertension and to clarify the physiological adaptations that 
take place.   
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Furthermore, a 12-week study including twenty-seven chronic heart failure patients (Wisloff 
et al. 2007), investigated the effects of HIIT compared against traditional aerobic training and 
a control group on cardiac structure and function. The study demonstrated significant 
improvements in cardiac, vascular and autonomic function after adherence to a long-term HIIT 
programme compared to aerobic training or a control group. There was a significantly greater 
increase in VO2max following HIIT compared to aerobic training (46% compared to 14%, 
P<0.001) which was associated with reverse left ventricular remodelling. The HIIT group was 
more effective in improving systolic function, with left ventricular ejection fraction 
significantly improving by 35% (P<0.01), accompanied by increases in systolic mitral annulus 
excursion and stroke volume by 30% and 17% (P<0.01) respectively. In addition, peak systolic 
mitral annulus velocity, an indicator of global contractility increased by 22% (P<0.01), whereas 
there were no significant changes in systolic function in the aerobic or control groups.  It was 
also shown that HIIT was more effective in improving diastolic function, with HIIT but not 
aerobic training significantly improving E/E’ and E/A ratio by 49% and 15% (P<0.01, P<0.05) 
respectively. Isovolumetric relaxation time significantly decreased by 22% (P<0.05) only in 
the HIIT group. HIIT and aerobic training reduced E/E’ by 26% (P<0.001) and 15% (P<0.043) 
respectively. The results from this study give insight into the benefits of prescribing HIIT as a 
rehabilitative intervention in stable chronic heart failure patients. 
The literature reviewed demonstrates how HIIT programmes can induce physiological 
adaptations that are beneficial to cardiovascular health in different populations. Empirical 
literature shows how acute and chronic sessions of HIIT can alter cardiac structure and 
function. However there has been no research to examine the effects of a short-term HIIT 




It is well recognised that taking part in a HIIT programme offers cardiovascular protective 
adaptations that can reduce risk factors of CVD, like that of traditional aerobic training 
programmes, but with less time commitment. However, literature supporting HIIT and the 
effect on cardiac structure and function in physically inactive populations is limited and can 
be considered equivocal in regard to the amount, mode, frequency and intensity of what is the 
best intervention for improvements. The reported benefits in cardiac structure and function 
can be seen in hypertensive patients, physically inactive older men, patients with type 2 
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diabetes, patients with chronic heart failure as well as patients with other cardio-metabolic 
chronic diseases. Current research supports HIIT as an effective intervention which can 
improve traditional and novel risk factors for CVD in healthy and high-risk populations. 
Therefore, the aim of this study is to investigate the effects upon cardiac structure and 
function in a physically inactive population following a 4-week HIIT intervention.  
1.10: Hypothesis 
 
Considering empirical research, the following hypothesis can be theorised; 
Experimental hypothesis (Ha) - There will be a statistically significant difference in cardiac 
structure and function measured via a transthoracic echocardiogram in participants completing 
a HIIT intervention compared to a control group.  
Null hypothesis (H0) - There will not be a statistically significant difference in cardiac structure 
and function measured via a transthoracic echocardiogram in participants completing a HIIT 
intervention compared to a control group. 
 
2.0: Method 
2.1: Ethical approval and study population 
 
All procedures for the current investigation conformed to Canterbury Christ Church 
Universities Research Governance Handbook, and the Canterbury Christ Church Universities 
Faculty of Social and Applied Sciences Research Ethics Committee approved the study. 
Signed informed written consent and a completed physical activity readiness questionnaire 
was obtained from all participants.  
Forty-five participants including a mix of male and females who were physically inactive 
from Canterbury Christ Church University volunteered to participate in the study. The 
participant’s demographics (see table 2.1), including age (Control = 22 ± 3.5 years, HIIT = 21 
± 1.7 years) and height (Control = 172.4 ± 8.8 cm, HIIT = 173.7 ± 9.5 cm) were recorded 
prior to each phase of the study. Height was measured using a stadiometer (Seca model 220, 
Seca Gmbh & co.kg, Hamburg, Germany) and weight was measured using balance scales 




Table 2.1: Participants demographic information pre-intervention. 
 Control (n=20) 
Mean ± SD 
HIIT (n=21) 
Mean ± SD 
 Pre Pre 
Weight (kg) 74.3 ± 15.9 73.9 ± 14.4 
BMI (kg.m2) 24.9 ± 4.5 23.4 ± 3.2 
BSA (m2) 1.87 ± 0.22 1.84 ± 022 
Resting sBP (mmHg) 120.9 ± 9.6 121.2 ± 10.3 
Resting mBP (mmHg) 88.6 ± 7.6 87.8 ± 8.4 
Resting dBP (mmHg) 69.9 ± 7.4 69.5 ± 10.8 
Resting PP (mmHg) 51.2 ± 8.6 51.7 ± 12.3 
 
Although forty-five participants were recruited for the study, it must be documented that due 




All cardiac structural and functional parameters were measured by Quantitative 2-D 
transthoracic echocardiography, a method which enables characterization of left ventricular 
remodelling in normal subjects and in a variety of heart diseases (Lang et al. 2006). 
Transthoracic echocardiography was performed using a commercially available, portable 
ultrasound system (Vivid‐q, GE Healthcare, Milwaukee, Wisconsin) with a 1.5–3.6 MHz 
phased array transducer (M4S‐RS Matrix cardiac ultrasound probe), pre-and post the 4-week 
intervention. All image acquisitions and measurements were performed as recommended by 
the American Society of Echocardiography (Lang et al. 2015). Three consecutive cardiac 
cycles were recorded and stored for offline analysis using commercial software on a 
proprietary workstation (EchoPAC; V.113.0.x, GE Healthcare), with the results averaged. 
Images were obtained in parasternal long axis and short axis level to mitral valve and apex, 
and apical 2‐, 3‐, and 4‐chamber views at baseline following 15 min of supine rest. Left 
ventricular mass was calculated according to Devereux et al. (1986). Left ventricular ejection 
fraction was determined by the modiﬁed biplane Simpson’s rule. Pulsed wave Doppler was 
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used to record transmitral ﬂow in the apical four chamber view. Tissue Doppler velocities 
were acquired at the lateral mitral annulus. LV ﬁlling pressure was estimated from the mitral 
E/E’ ratios (Ommen et al. 2000). Doppler-echocardiography has emerged as important 
clinical tool providing reliable and useful data on cardiac performance (Mandinov et al. 
2000). 
Resting blood pressure was measured using a Dinamap blood pressure monitor (Dinamap, 
PRO 200, GE Medical Systems Information Technologies GmbH, Munzinger Strasse 3, 
79111, Freiburg, Germany) to confirm blood pressure status. The Dinamap PRO 200 has 
been shown to be a valid tool for measuring resting blood pressure and is approved by the 
American National Standards Institute (Lai et al. 2013).  
A Wattbike cycle ergometer (Wattbike Ltd, Nottingham, UK) programmed using Wattbike 
expert software (V2.50.42, Wattbike Ltd, Nottingham, UK) was used for a Wingate test 
protocol in the HIIT intervention. It has been reported that the measurements produced from 
the Wattbike are valid and reproducible (Driller, Argus, & Shing, 2013). Hopker et al. (2010) 
demonstrated that the Wattbike is sufficiently accurate to track performance changes over 
time and thus would serve as an acceptable training tool for both trained and untrained 
populations. The Wingate protocol developed in the 1970s is documented as being the most 
common HIIT intervention used in studies (Shiraev & Barclay, 2012). The participant’s 
Wattbike resistance during the 30 second maximal sprints were prepared to 7.5% of the 

































Figure 2.1. Flow diagram depicting the flow of participants at each stage of the study. 
  
Analysed (n=20) 
Excluded from analysis (n=0) 
 
Analysed (n=21) 
Excluded from analysis (n=0) 
 
Completed intervention (n=21) 
Discontinued intervention (did not 
re-contact, n=1) 
 




• Declined to 
participate (n=2) 
 
Allocated to control 
Received allocated intervention 
(n=21) 
 
Allocated to HIIT 




Completed intervention (n=20)  
Discontinued intervention (could 






Prior to testing the participants were required to abstain from caffeine and alcohol for 24 
hours. All participants were required to maintain their normal lifestyle and dietary patterns 
throughout the 4-week investigation. Prior to testing the participants were randomised, using 
stratified randomisation for gender into either the HIIT group or control group, to ensure an 
equal number of male and female participants in each condition, in addition to reducing any 
bias with pre-test variables (Blüher et al. 2017). The participants were then required to have 
15 minutes seated rest while they had their seated resting BP and HR recorded. A reading 
was taken every 5 minutes in order to calculate an average. Following blood pressure 
assessment, A transthoracic echocardiogram was performed on each participant by using a 
portable ultrasound system (Vivid‐q, GE Healthcare, Milwaukee, Wisconsin) with a 1.5–
3.6 MHz phased array transducer (M4S‐RS Matrix cardiac ultrasound probe) to measure 
cardiac structural and functional parameters. The same sonographer acquired all images, with 
the participant examined in the left lateral decubitus position. This was performed pre-and 
post HIIT and Control phases. Upon completion of the 4- week intervention participants were 
asked to come into the lab 48 hours after the last HIIT session to monitor any potential 
changes. The rationale behind participants coming in 48 hours prior to the last HIIT session is 
to ensure that sufficient time had been left for any post exercise hypotension to subside 
(Forjaz et al. 2000).  
2.3.1. HIIT Group  
The HIIT intervention consisted of supervised sessions 3 times a week for 4 weeks. Each 
HIIT session consisted of a 5-minute warm up, followed by 3x 30 second maximal sprints at 
a resistance of 7.5% body weight separated by a 2-minute active recovery period, similar to 
the HIIT protocol reported by Shiraev & Barclay (2012), to improve cardiovascular and 
metabolic health. Each session lasted approximately 12 minutes. HIIT sessions were 
performed in groups with verbal encouragement given throughout to maximise beneficial 
effects from the intervention (Burke et al. 2006). Upon completion of the 4-week intervention 
the participants underwent the same procedure as pre-testing, 48 hours after the final HIIT 
session, in order to assess the influence HIIT had upon cardiac variables.  
2.3.2. Control Group 
The participants were instructed to maintain their lifestyle and dietary habits for a 4-week 
period. Once completed the participants underwent the same procedure as pre-testing to 




2.4: Power Calculation 
 
Based on operator coefficient of variation for diastolic function and estimated filling pressure 
(primary outcome variables) using transthoracic echocardiography, a sample size of 14 to 
17 participants in each group has 80% power to detect a significant difference in diastolic 
function and estimated filling pressure, respectively, with a 2-sided p<0.05. It was estimated 
a drop-out rate of between 10-30% leading to an overall sample size of 44 participants (22 in 
each group).   
 
2.5: Data Analysis 
 
All data was analysed using statistical package for social sciences (SPSS V22.0, release 
version for Windows; SPSS Inc., Chicago IL, USA). Unless specified otherwise, continuous 
variables are presented as mean ± SD. Change in cardiac parameters in control and HIIT 
groups were analysed using an analysis of covariance (ANCOVA), as the data was normally 
distributed. Statistically significant data was report as P< 0.05.     
 
3.0: Results 
Forty-five participants were recruited for the study. Forty-one participants completed the 
intervention, 21 in the HIIT group and 20 in the control group. Two participants declined to 
participate before being allocated to a group, due to lack of time. One participate removed 
themselves from the control group due to an inability to complete post testing. One 
participant removed themselves from the HIIT intervention due to unknown reasons. There 
were no adverse effects following the HIIT sessions. There was no significant change in the 
participants pre and post demographic data between groups following the intervention (see 
table 3.1).  
 
 
Table 3.1: Participants demographic data pre and post intervention. 
 Control (n=20) HIIT (n=20) 
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Mean ± SD Mean ± SD 
 Pre Post Pre Post 
Weight (kg) 74.3 ± 15.9 74.2 ± 15.7 73.9 ± 14.4 74.3 ± 15 
BMI (kg.m2) 24.9 ± 4.5 24.8 ± 4.4 23.4 ± 3.2 23.5 ± 3.4 
BSA (m2) 1.87 ± 0.22 1.87 ± 0.23 1.84 ± 022 1.84 ± 0.23 
Resting sBP (mmHg) 120.9 ± 9.6 119.7 ± 10.9 121.2 ± 10.3 114.6 ± 8.8* 
Resting mBP (mmHg) 88.6 ± 7.6 88.8 ± 9.3 87.8 ± 8.4 85 ± 6.3 
Resting dBP (mmHg) 69.9 ± 7.4 69.9 ± 8.8 69.5 ± 10.8 66.1 ± 5.9 
Resting PP (mmHg) 51.2 ± 8.6 49.7 ± 7.9 51.7 ± 12.3 48.5 ± 8.34 
Values are presented as mean ± SD. sBP, systolic blood pressure; dBP, diastolic blood 
pressure; mBP, mean blood pressure; PP, pulse pressure. * indicates significant (P < 0.05) 
difference in the pre- to post-change value between control and HIIT intervention group.  
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3.1: Haemodynamic Parameters 
 
Following 4 weeks of HIIT there was a significant reduction in resting SBP (-6.86 ± 8.76 mmHg) compared against the control group (-1.15 ± 
9.4 mmHg, P = 0.041). There were no significant differences found in resting DBP or MBP in either the HIIT group or control group (see table 
3.1). As shown in figure 3.1A, there was a significant reduction in resting heart rate (65.59±10.15 to 63.05±13.42 b·min-1) in the HIIT 
intervention and no significant change (60.7±8.19 to 61.3±7.32 b·min-1; P=0.013) during the control period. As shown in figure 3.1B, there was 
a significant increase in SV (55.48±16.27 to 64.24±20.62ml) in the HIIT intervention and no significant change (56.8±11.94 to 59.4±14.81ml; 
P=0.015) during the control period. As illustrated in figure 3.1C, there was no significant change in either group in cardiac output.  
 
Figure. 3.1. Mean heart rate (A), stroke volume (B), cardiac output (C) change values at rest for the control (filled circles) and HIIT (open 
circles) conditions. Error bars indicate standard error of the mean. * Significant (P<0.05) difference in the control and HIIT change value.  
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3.2: Cardiac Structural Parameters 
 
As displayed in table 3.2 there was no significant change in either group in cardiac structural 
parameters. 
 
Table 3.2 displays changes in cardiac structural parameters following HIIT and control period 
Parameter Control HIIT 
 Pre b Post Pre b Post 
IVSd (cm) 0.7 ± 0.1 0.6 ± 0.1 0.71± 0.14 0.68 ± 0.12 
LVIDd (cm) 4.6 ± 0.42 4.6 ± 0.39 4.63 ± 0.42 4.64 ± 0.46 
LVPWd (cm) 0.8 ± 0.11 0.8 ± 0.11 0.86 ± 0.16 0.82 ± 0.14 
LVIDs (cm) 3.7 ± 0.4 3.7 ± 0.36 3.47 ± 0.36 3.52 ± 0.38 
FS (%) 20.4 ± 7.81 19.7 ± 5.65 24.76 ± 7.12 23.79 ± 7.47 
LA (cm) 3 ± 0.22 3 ± 0.27 3.07 ± 0.36 3.05 ± 0.38 
LVLd (cm) 8 ± 0.71 8.1 ± 0.71 8.06 ± 0.66 8.16 ± 0.73 
LVLS (cm) 6.5 ± 0.58 6.3 ± 1.02 6.45 ± 0.62 6.43 ± 0.64 
LVEF (%) 50.1 ± 5.61 48.3 ± 5.88 49.61 ± 6.01 49.18 ± 6.05 
LVM (g) 110.88 ± 29.62 106.21 ± 26.45 119 ± 37.27 112.4 ± 29.6 
RWT (cm) 0.35 ± 0.04 0.35 ± 0.05 0.37 ± 0.07 0.35 ± 0.06 
Note: IVSd, interventricular septum thickness at diastole; LVIDd, 
Left Ventricular Internal Dimension -Diastole; LVPWd, Left Ventricular Posterior Wall 
Dimensions; LVIDs, Left Ventricular Internal Dimension - Systole; FS, Fractional 
Shortening; LA, Left Atrium; LVLd, Left Ventricle Length Diastole; LVLs, Left Ventricle 
Length Systole; LVEF, Left ventricular ejection fraction; LVM, Left Ventricular Mass; RWT, 
Relative wall thickness. Values are presented as mean ± standard deviation. b Adjusted for 
baseline value for ANCOVA. * Indicates significant (P < 0.05) difference in the pre- to post- 




3.3: Cardiac Function Parameters 
 
As illustrated in table 3.3, it can be noted that there was a significant increase in LVEDV 
(115.59 ± 28.34 to 131.94 ± 33.40ml) in the HIIT intervention and no significant change 
(117.1 ± 27.93 to 121.4 ± 24.5; P=0.025) during the control period. There was a significant 
reduction in E/A ratio (1.98 ± 0.48 to 1.95 ± 0.55) in the HIIT intervention and no significant 
change (2.02 ± 0.34 to 2.05 ± 0.29; P=0.027). There was a significant reduction in lateral 
E/E’ ratio (4.67 ± 1.28 to 4.20 ± 0.87) in the HIIT intervention and no significant change 
(4.23 ± 1.16 to 4.57 ± 1.27; P=0.04) in the control group. There was a significant reduction in 
septal E/E’ ratio (6.74 ± 1.41 to 6.23 ± 1.06) in the HIIT intervention and no significant 
change (6.35 ± 1.98 to 6.67 ± 1.9; P=0.01) in the control group. There was a significant 
reduction in average E/E’ ratio (5.41 ± 1.17 to 5.22 ± 0.89) in the HIIT intervention and no 
significant change (5 ± 1.83 to 5.37 ± 1.38; P=0.002) in the control group.  
 
Table 3.3 displays changes in cardiac function parameters following HIIT and control period 
Parameter Control HIIT 
 Pre b Post Pre b Post 
LVEDV (ml) 117.1 ± 27.93 121.4 ± 24.5 115.59 ± 28.34 131.94 ± 33.40* 
LVESV (ml) 62.6 ± 17.71 63.7 ± 17.23 56.21 ± 14.94 66.64 ± 16.29 
MV E Vel(m/s) 0.79 ± 0.17 0.82 ± 0.17 0.79 ± 0.15 0.8 ± 0.13 
MV DecT (m/s) 181.5 ± 21.51 176.3 ± 16.66 186.33 ± 40.88 166.26 ± 26.99 
MV Dec Slope 
(m/s2) 
4.5 ± 1.08 4.6 ± 0.99 4.57 ± 1.37 4.99 ± 1.06 
MV A Vel 
(m/s) 
0.48 ± 0.11 0.4 ± 0.08 0.41 ± 0.06 0.44 ± 0.11 
MV E/A Ratio 2.02 ± 0.34 2.05 ± 0.29 1.98 ± 0.48 1.95 ± 0.55* 
E’ Lateral 
(m/s) 
0.18 ± 0.03 0.18 ± 0.03 0.19 ± 0.04 0.19 ± 0.03 
E/E’ Lateral 4.23 ± 1.16 4.57 ± 1.27 4.67 ± 1.28 4.20 ± 0.87* 
A’ Lateral 
(m/s) 
0.07 ± 0.02 0.07 ± 0.02 0.06 ± 0.02 0.07 ± 0.02 
S’ Lateral 
(m/s) 
0.11 ± 0.02 0.11 ± 0.03 0.1 ± 0.02 0.11 ± 0.02 
E’ Septal (m/s) 013 ± 0.02 0.13 ± 0.02 0.13 ± 0.02 0.13 ± 0.02 
E/E’ Septal 6.35 ± 1.98 6.67 ± 1.9 6.74 ± 1.41 6.23 ± 1.06* 
Avg E/E’ 5 ± 1.83 5.37 ± 1.38 5.41 ± 1.17 5.22 ± 0.89* 
A’ Septal (m/s) 0.08 ± 0.03 0.08 ± 0.01 0.09 ± 0.04 0.08 ± 0.01 
S’ Septal (m/s) 0.09 ± 0.02 0.08 ± 0.01 0.1 ± 0.01 0.09 ± 0.01 
RV E’(m/s) 0.14 ± 0.03 0.14 ± 0.02 0.14 ± 0.02 0.15 ± 0.03 
RV A’ (m/s) 0.1 ± 0.03 0.09 ± 0.03 0.1 ± 0.02 0.1 ± 0.02 
RV S’ (m/s) 0.13 ± 0.02 0.13 ± 0.02 0.14 ± 0.02 0.16 ±0.11 
TAPSE (cm) 1.94 ± 0.18 1.95 ± 0.21 2.02 ± 0.21 2.06 ± 0.18 
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Note: LVDEV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic 
volume; LVEF, E, peak mitral inflow velocity during early filling; DecT, deceleration time; 
A, peak mitral inflow during atrial systole; E’, peak annulus tissue velocity during early 
filling; A’, peak annulus tissue velocity during atrial systole; S’, systolic peak flow velocity in 
left ventricular outlet tract; TAPSE, Tricuspid annular plane systolic excursion. Values are 
presented as mean ± standard deviation. b Adjusted for baseline value for ANCOVA. * 
Indicates significant (P < 0.05) difference in the pre- to post- delta value between control and 





3.4: Cardiac Time Intervals  
As illustrated in figure 3.2, it can be noted that there was a significant reduction in isovolumetric relaxation time (81.23 ± 12.85 to 77.83 ± 9.81 
m/s) in the HIIT intervention and no significant change (83.45 ± 10.36 to 85.71 ± 8.24 m/s; P=0.022) in the control group. It can also be noted 
that there was no significant change in either group in isovolumetric contraction and ejection time. 
 
 
Figure. 3.2. Isovolumetric contraction (A), ejection time (B), isovolumetric relaxation (C) change values at rest for the control (filled circles) and 
HIIT (open circles) conditions. Error bars indicate standard error of the mean. * Significant (P<0.05) difference in the control and HIIT change 
value.   
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4.0: Discussion  
 
Empirical literature indicates that participation in regular physical activity can reduce the risk 
of chronic diseases related to unhealthy lifestyles. Findings from the present study offer new 
and consistent research which demonstrate the response of HIIT on health markers in a 
physically inactive population. These findings offer insight of the role of HIIT and the 
potential it could have on primary health care and physical activity guidelines.     
4.1: HIIT and Myocardial Compliance 
 
Subsequent to the 4-week HIIT intervention, it can be noted that resting heart rate was 
significantly reduced by -4.47 ± 5.68 b.min-1 (P=0.013). It can also be observed that SV (6.56 
± 8.04 ml; P=0.015) and LVEDV (16.35 ± 20.44 ml; P=0.025) significantly increased. These 
findings indicate that myocardial compliance can be improved following a short term HIIT 
intervention compared against a control group, which could be beneficial to individuals who 
cite lack of time as their main barrier to regular exercise.  
Findings from the present study coincide with those by Molmen-Hansen et al. (2012) as they 
reported improvements in resting heart rate, stroke volume and end diastolic volume following 
a 12-week HIIT intervention. Molmen-Hansen’s study used a similar HIIT protocol to the 
present study and compared it to an aerobic training group, in individuals with hypertension. 
Molmen-Hansen et al. (2012) reported reductions of 3.8 b.min-1 following the HIIT 
intervention, as well as increases of 8ml in SV and 12ml in LVEDV, opposed to no significant 
changes in the aerobic group, further reinforcing the benefits of HIIT. Heydari, Boutcher & 
Boutcher’s (2013) investigation also found reductions in resting heart rate of 6.2 b.min-1 
following a 12-week HIIT intervention. In comparison to these findings it could be theorised 
that if the present study was longer, further improvements in myocardial compliance could be 
observed. It can also be noted that the participants in the present study had greater 
improvements compared to Molmen-Hansen in a shorter time-period. The present study had 
shorter work periods and shorter recovery periods which may have allowed the participants to 
perform at a higher intensity compared to the participants in Molmen-Hansen’s study. This 
would suggest that the exercise protocol in the present study permits a longer duration of the 
training period to be spent at a higher percentage of V02max. Which could possibly explain the 
greater adaptations in the present study.  
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Empirical literature frequently acknowledges the improvements in myocardial compliance 
following HIIT interventions, however, the mechanisms underlying these improvements are 
complex and are yet to be completely understood. However, it has been suggested that the 
underlying mechanisms that potentially could explain improvements in myocardial compliance 
following HIIT interventions are similar to those of aerobic exercise, findings that have been 
reported in many longitudinal studies surrounding HIIT and aerobic exercise training (Lavie et 
al. 2015).  
A possible mechanism explaining a reduction in resting HR following HIIT, which coincides 
with the result of the present study is the increase in SV. It has been reported that increased 
LVEDV is associated with increased ventricular preload. Higher LVEDV has previously been 
found to be a consequence of increased venous return, which stretches the sarcomeres, thereby 
increasing their preload. Changes in ventricular preload have been shown to dramatically effect 
stroke volume due to the Frank-Starling mechanism. According to the Frank-Starling law, the 
increase in blood volume causes a direct increase in myocardial contractility and to maintain 
cardiac output, resting HR can decrease as a response to the higher SV. This response 
influences a reduction in myocardial workload, which has been reported to be beneficial in the 
prevention of CVD (Heydari, Boutcher & Boutcher, 2013).  
Another possible mechanism explaining a reduction in resting HR following the HIIT 
intervention could be improvements in cardiac autonomic parameters. Research has shown that 
short-term HIIT intervention increases parasympathetic activity and decreases sympathetic 
activity to the heart at rest (Besnier et al. 2017). This has been shown to improve cardiovascular 
health by increasing stroke volume, heart rate variability whilst reducing resting HR, peripheral 
resistance and blood pressure parameters (Lanfranchi & Somers, 2002). An improvement in 
cardiac autonomic function would indicate a greater sympathovagel balance (Goldstein et al. 
2011). This response would offer a cardio-protective effect as well as reducing the incidence 
of CVD (Heydari, Boutcher & Boutcher, 2013).  
Alternatively, the reductions in resting HR could possibly be linked with a training-induced 
increase in vagal activity (Hautala, Kiviniemi & Tulppo, 2009). It has been reported that 
HIIT interventions can increase parasympathetic activity whilst also decreasing sympathetic 
activity over the sinus node autorhythmicity when at rest (McCorry, 2007).  This 
improvement in sympathovagal balance after the interval exercise session, could represent a 
greater cardio protective effect (Borresen & Lambert, 2008). The research that explains the 
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possible mechanisms responsible for improving cardiac vagal modulation is limited, 
however, angiotensin II and nitric oxide are potential mediators (Routledge et al. 2010). 
Further research is required to clarify the role of nitric oxide and its potential influence on 
cardiac vagal tone.   
The improvements in resting HR could also be attributed to exercise-induced sinus 
bradycardia (D’Souza et al. 2014). A case study by D’Souza et al. (2014) investigating the 
effects of exercise on sedentary mice found electrophysiological adaptations in the sinus 
node. The study observed training induced remodelling of pacemaker ion channels, most 
notable was the downregulation of HCN4, mRNA and protein, possibly due to a decrease in 
density of If. However, it was also noted that there was widespread remodelling of the sinus 
node and it is possible that other aspects of the remodelling may have had an impact on 
pacemaker mechanisms.   
4.2: Cardiac Function 
 
HIIT improved diastolic function significantly when compared against the control group. The 
changes in tissue Doppler measurements were significant, while it can be noted the control 
group suffered further impairment. The positive effect of HIIT on myocardial function in other 
CVD has been well documented in previous literature (Cassidy et al. 2015; Molmen-Hansen 
et al. 2012).  
The findings from the present study suggest that the improved SV with enhanced ventricular 
preload and recruitment of the Frank-Starling mechanism, are associated with enhanced 
diastolic filling indices. In the HIIT group, favourable trends were observed for improvements 
in E/E’ (5.41 ± 1.17 to 5.22 ± 0.89; P=0.002) and E/A ratio (1.98 ± 0.48 to 1.95 ± 0.55; 
P=0.027). Even though these changes were modest, all participants had normal diastolic 
function. However, these findings may have important clinical implications in patients with 
borderline and established diastolic dysfunction, due to diastolic function being a strong 
independent predictor of all-cause mortality (Ha et al. 2004). 
The significant reduction in E/A ratio suggests that the myocardium is more compliant and 
quicker to relax following HIIT. This enables greater filling and emptying of the ventricle, 
demonstrated from the increase in SV and LVEDV. Improved diastolic filling is also 
consistent with the decrease in the isovolumetric relaxation rate following the HIIT 
intervention (Thomas & Weyman, 1991). A reduced isovolumetric relaxation time might be 
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indicative of an enhanced atrioventricular pressure gradient and may be the precursor to the 
enhanced left ventricular early filling, observed by the improvement in E/A ratio (Lalande & 
Johnson, 2008). Diastolic dysfunction is a common finding of the hypertensive heart and an 
independent predictor of mortality (Redfiled et al. 2003), thus emphasising the clinical 
relevance of these findings.  
Further mechanisms explaining the improvements in diastolic function could be associated 
with factors effecting myocardial twist and deformation. Previous literature has identified 
reductions in cardiac torsion following a HIIT protocol (Cassidy et al. 2015). Research has 
identified that cardiac torsion describes the twisting motion of the myocardium during 
contraction and reflects the dominance of epicardial fibres over endocardial fibres, therefore, 
improvements in cardiac torsion suggest a reduction in endocardial damage following HIIT 
(Buckberg et al. 2008). It is plausible to suggest that improvements in myocardial torsion 
could be a mechanism for generating stored energy during systole, which is released during 
early diastole to produce ventricular recoil, upward annular motion and suction, enabling 
greater rapid filling of the ventricle (Tan et al. 2009).   
E/E’ ratio has been shown to be a non-invasive marker of left ventricular filling pressure at rest 
(Sato et al. 2017). The significant reduction in E/E’ following the HIIT intervention suggests 
lower myocardial workload at rest. A possible mechanism explaining this adaptation is an 
improvement in exercise capacity. E/E’ ratio has been shown to have a significant correlation 
with exercise capacity, namely VO2max (Edelmann et al. 2011).  
Existing research has identified significant improvements in VO2max following a 2 week HIIT 
intervention (Astorino et al. 2012). This evidence could suggest significant cardiorespiratory 
adaptations following a short term HIIT intervention. It is therefore plausible to suggest that if 
VO2peak had been measured in the present study, improvements alongside E/E’ could have been 
discovered. An increase in peak aerobic capacity apparent by the significant reduction in E/E’ 
ratio is associated with a lower risk of all-cause mortality and major cardiovascular events 
(Hillis et al. 2005). However, future research is needed to clarify these findings, as 
generalisation cannot be made in the present population.  
Further mechanisms explaining the significant reduction in left ventricular filling pressure 
could be adaptations in the pulmonary, vascular or peripheral systems. Research suggests that 
a significant reduction in HR combined with improvements in blood pressure parameters, could 
indicate a significantly reduced myocardial oxygen demand (Fletcher et al. 2013). These 
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significant reductions could result in an anti-ischaemic effect which is beneficial to 
cardiovascular health (Fletcher et al. 2013).        
Reductions in E/E’ ratio because of improved blood pressure parameters would suggest 
improvements in endothelial function and sympathetic tone. Previous research has shown HIIT 
to be superior to traditional aerobic training programmes for improving flow mediated dilation 
(Ramos et al. 2015). It has been suggested that the sheer stress experienced during HIIT, 
increases the stimuli for increasing NO availability in the endothelium. As a consequence of 
improved flow mediated dilation, there would be greater perfusion and oxygen supply to 
peripheral tissue. This vasodilation because of enhanced endothelial function would indicate a 
reduction in systemic vascular resistance, this could potentially explain the reduction in left 
ventricular filling pressures and improvement in diastolic function.  
Research indicates that adherence to an aerobic or HIIT program can lead to physiological 
adaptations in the vasculature and trigger anti-atherosclerotic adaptations (Green, 2009). A 
case study investigating the effect an exercise intervention had on the internal mammary 
artery (Hambrecht et al. 2003) reported an improvement in acetylcholine and adenosine-
mediated blood flow, indicating enhanced function of both the conduit and resistance artery 
endothelium-dependant vasodilator. It was also found that there was an increase in 
endothelial nitic oxide synthase and shear stress-related endothelial nitric oxide synthase 
phosphorylation. This infers that a shear stress-dependant mechanism may result in increased 
nitric oxide bioactivity as a result of exercise training (Green, 2009). These findings coincide 
with that of Fletcher et al. (2013) who found that adherence to an exercise programme 
increases arterial wall stress, which over a prolonged period can increase dilation capacity 
and lumen size. This could result in enhanced myocardial compliance as a result of reduced 
total peripheral resistance as well as contribute to the blood pressure reductions reported. 
The management and control of blood pressure is crucial for improving public health. 
Hypertension, is the most predominant pre-curser of cardiovascular disease and deaths globally 
(He & Whelton, 1997). Reductions in blood pressure lead to reduced myocardial workload and 
decrease the risk of major cardiovascular events. However, it can be noted that the mechanisms 
responsible remain unclear. It has been suggested that improvements in endothelial function, 
reductions in plasma renin activity and lower plasma noradrenaline are possible explanations 
to improvements observed at rest following exercise interventions. Further research is needed 
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to help understand the physiological adaptations on haemodynamic parameters following HIIT 
interventions.    
Following the 4-week HIIT intervention, it can be noted that isovolumetric relaxation time was 
significantly reduced (81.23 ± 12.85 to 77.83 ± 9.81 m/s; P=0.022), compared to no significant 
change in the control group. Myocardial time intervals are sensitive markers of cardiac 
dysfunction and can identify miniscule cardiac impairments which are unrecognised by 
conventional echocardiography (Biering-Sørensen et al. 2016). Improvements in isovolumetric 
relaxation time indicates improved myocardial performance, as a measure of active ventricular 
relaxation, which further supports the notion that HIIT is beneficial to diastolic function. A 
reduction in isovolumetric relaxation time is associated with a lower risk of all-cause mortality 
and major cardiovascular events (Biering-Sørensen et al. 2015).  
Following the HIIT intervention, adaptations at the cellular level could potentially explain 
reductions in isovolumetric relaxation time. Increased Ca2+ uptake into the sarcoplasmic 
reticulum results in faster relaxation rates in the myocardial cells due to improved diastolic 
Ca2+ handling in trained cardiomyocytes (Kemi et al. 2005; Kemi et al. 2008). This could 
potentially be recognised as an adaptation following the HIIT intervention due to the longer 
periods of diastole resulting in increased preload which due to the Frank-Starling mechanism 
increases SV, which has been shown to influence greater cardiovascular protective adaptations 
(Shephard & Balady, 1999). 
Relative to current physical activity guidelines, the findings observed from the present study 
found significant improvements in resting HR, SV and diastolic function can be accomplished 
when completing exercise training of a shorter duration, which have been previously associated 
with reduced CVD risk. The 4-week HIIT intervention was a time efficient strategy to induce 
myocardial functional adaptations in a group exercise setting compared to a control group. This 
study provides evidence that individuals who cite lack of time and motivation could benefit 
from a training programme similar to the present study. In relation to health, the clinical 
importance of these findings is significant as HR (Aune et al. 2017) and diastolic function (Sato 
et al. 2017) are independent predictors of CVD and as little as 4 weeks of HIIT observed in 
this study produce significant improvements in these markers. 
The findings from the present study highlight the possibility for short-term HIIT programmes 
as effective strategies for improving health. However, as the present study was only a short 
term HIIT intervention and had 4 drop outs, it is unknown whether adherence to long-term 
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HIIT interventions is sustainable. However, previous research has found that drop-out rates in 
a HIIT programme tend to be lower compared to traditional aerobic training programmes 
(Heydari, Boutcher & Boutcher, 2013). The findings from the present study demonstrate 
important clinical evidence in regards to HIIT frequency (3 days per week), low volume per 
session (3 x 30 seconds), low active recovery (2 minutes) and short-term duration (4-weeks) in 
a young population with pre-hypertension. It can be concluded that the significant 
improvements found from the present study identify a need for the current physical activity 
guidelines to adapt to allow for a potentially greater exercise adoption and adherence from the 
wider population.          
4.3: Limitations 
 
This study is not without limitation. In regards to the study population, it could be suggested 
that stress and anxiety from the student lifestyle and university assessments may have had an 
influence on a variety of variables measured throughout. In addition, there were no dietary 
recommendations, measurements of alcohol consumption or measurements of physical 
activity outside of testing throughout the duration of the study which could possibly affect the 
results. Participants were instructed to abstain from any structured exercise outside of the 
study and to maintain their normal daily living, however, this was not measure or recorded 
just confirmed verbally.  
Previous research investigating HIIT and cardiac structure and function in a young, 
physically inactive population is limited and can be considered equivocal, making the results 
difficult to generalise to a larger population. In the present study HIIT produced significant 
changes in myocardial compliance and diastolic function. Therefore, future research in 
young, physically inactive populations should consider utilising this protocol in order to 
make comparisons and decisions on its clinical effect. 
It is also possible that due to the HIIT being performed in a group environment, this may 
have influenced the engagement, enjoyment, improved adherence and maximal effort 
produced from the participants within the study. HIIT performed in isolation may have 
affected adherence and training intensity, which may affect physiological adaptations.  
Due to the control group receiving no treatment it may be suggested that there is a potential 
for nocebo effects to take place. Future research may benefit from developing strategies to 
mitigate its impact on research findings and clinical practice.    
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The mechanisms responsible for the changes observed following the HIIT intervention are 
complex and likely multifaceted. It is possible that the use of blood tests to measure blood 
plasma volume and other important biomarkers could be used to ascertain potential 
mechanisms supporting physiological adaptation. The use of VO2peak testing could have also 
been useful for measuring cardiorespiratory adaptations. The use of blood tests was 
unavailable for the present study due to lack of training and VO2peak was not measured due to 
lack of research time. In addition, methods used to assess vascular function may have 




The findings of the present study demonstrate that a 4-week HIIT programme can 
significantly improve diastolic function and reduce resting blood pressure when compared 
against a control group. These findings support HIIT as a time-efficient strategy to induce 
significant adaptations in cardiovascular health. Therefore, the null hypothesis is rejected. 
Continued engagement in regular physical activity is required to maintain and/or produce 
chronic adaptations from exercise, as well as limiting cardiovascular risk factors and all cause 
morality. As such, future research is required to ascertain the long-term physiological 
responses and adaptations to HIIT compared to alternative exercise training interventions. 
Longer-term HIIT interventions may provide evidence to support this method of exercise 
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6.1: Appendix 3- Physical Activity Readiness Questionnaire (PARQ)  
 
Department of Sport Science, Tourism and Leisure 
 




Date of Birth: ………………  Age: ………   Sex: ….…. 
 
Please answer the following questions by circling the appropriate response and if necessary 
providing extra information in the spaces provided. 
 




1. How would you describe your present level of fitness?  
Untrained / Moderately trained / Trained / Highly trained 
2. Average number of hours spent exercising   ………….………….per wk 
3. How would you describe your present bodyweight?  
Underweight / Ideal / Slightly overweight / Very overweight 
4. How would you describe your smoking habits?   
Non smoker / Previous smoker / Currently smoking 
5. How would you describe your alcohol intake? 
Never Drink / An occasional drink / A drink every day / More than one drink a day       
 (Note 1 drink = 1 unit) 




If you have answered yes, please give 
details:…………………………………………………. 
7. Are you presently taking any form of medication?     Yes 
/ No 
If you have answered yes, please give details: 
………………………………………………… 
8. Do you suffer or have you ever suffered from any of the following? 
a.  Diabetes    Yes / No b.  Asthma   Yes 
/ No 
c.  Epilepsy    Yes / No d.  Bronchitis   Yes 
/ No 
e.  Any form of heart complaint Yes / No f.  Serious Back or Neck Injury Yes 
/ No 
g.  High blood pressure  Yes / No h.  Aneurysm 1 or Embolism2 Yes / No 
1: Arterial wall weakness causing dilation. 2: Obstruction in the Artery. 
9. Is there a history of heart complaint in your family?      
Yes / No 
If you have answered yes, please give details: 
………………………………………………… 
10. Do you have any allergies?         
Yes / No 




11. Do you currently have any form of muscle or joint injury?     
Yes / No 
If you have answered yes, please give details: 
………………………………………………… 
12. Have you had to suspend your normal training/physical activity in the last two weeks? 
Yes / No 





6.2: Informed Consent 
 
The full details of the tests have been explained to me. I am clear about what will be involved 
and I am aware of the purpose of the tests. 
 
I know that I am not obliged to complete the tests. I am free to stop the test at any point and for 
any reason. 
 
The test results are confidential and will only be communicated to others such as my coach if 
agreed in advance. 
 
As far as I am aware, there is nothing that might prevent me from successfully completing the 
tests that have been outlined to me. 
 
 
Signature of Participant: ……………………………………………….. 
 
 
Signature of Sport Scientist: ……………………………………….. 
 
 
Date: ………………… 
 
 
